Synbias Pharma Ltd.
Records under this name other than patents Synbias Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Synbias Pharma Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,388,083 | Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics Term ended Term ended Mar 4, 2026 · From the USPTO record | Term ended | Term ended Mar 4, 2026 | From the USPTO record |
| US 8,357,785 | Method of aralkylation of 4′-hydroxyl group of anthracylins Lapsed on the fee record Ended Jan 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2025 | From the USPTO record |
| US 7,485,707 | Thermally stable crystalline epirubicin hydrochloride and method of making the same Term ended Term ended Jan 17, 2025 · From the USPTO record | Term ended | Term ended Jan 17, 2025 | From the USPTO record |
| US 7,053,191 | Method of preparing 4-R-substituted 4-demethoxydaunorubicin Term ended Term ended Apr 23, 2024 · From the USPTO record | Term ended | Term ended Apr 23, 2024 | From the USPTO record |
| US 8,846,882 | Method of producing 4-demethoxydaunorubicin Formerly held Lapsed on the fee record Ended Sep 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 30, 2022 | From the USPTO record |
| US 8,802,830 | Synthesis of epirubicin from 13-dihydrodaunorubicine Lapsed on the fee record Ended Aug 12, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 12, 2022 | From the USPTO record |
| US 9,035,032 | Method for preparing 4-demethyldaunorubicin Lapsed on the fee record Ended May 19, 2019 · From the USPTO record | Lapsed on the fee record | Ended May 19, 2019 | From the USPTO record |